Scarica l'app Stockscreener
0.8426
3.08%
-0.0268
Dopo l'orario di chiusura:
.84
-0.0026
-0.31%
Aptorum Group Ltd Borsa (APM) Ultime notizie
APM News | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Aptorum Shareholders Approve Proposed Merger With DiamiR Biosciences - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Aptorum Group Limited Announces Board of Directors Appointments - marketscreener.com
Aptorum shareholders approve merger with DiamiR Biosciences By Investing.com - Investing.com South Africa
Aptorum Group Limited and DiamiR Biosciences Corp. Shareholders Approve Merger Transaction - Quiver Quantitative
Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - Yahoo Finance
Aptorum Group Limited (APM) Hovers Near Support at $0.80 After Marginal DeclinePut Spread Alert - newsline.com
APM | Aptorum Group Limited Class Insider Trading - Quiver Quantitative
APM Technical Analysis | Trend, Signals & Chart Patterns | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Why Is Aptorum Group Limited (APM.PA) Stock Down Today? - Meyka
TradingKey - TradingKey
Aptorum Group to Domesticate, Merge with DiamiR (NASDAQ: APM) - Stock Titan
Is Aptorum (APM) stock considered high volatility (Slight Gain) 2026-04-22Swing Trade - newser.com
Can Aptorum (APM) Stock Double in 2026 | Price at $0.93, Up 0.29%Continuation Pattern - Newser
XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI
APRE PE Ratio & Valuation, Is APRE Overvalued - Intellectia AI
APM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aptorum Group Soars Over 20% as Market Deciphers Regulatory Chaos and Sector Growth Signals - Bitget
DiamiR merger gives Aptorum (NASDAQ: APM) holders 30% of new Niki BioSolutions - stocktitan.net
Aptorum (NASDAQ: APM) to merge with DiamiR; domestication and share issuance - Stock Titan
Direxion Daily AMZN Bull 2X Shares (NASDAQ:AMZU) Short Interest Up 22.7% in March - Defense World
APTORUM GROUP PB Ratio: 0.29 | Possible Value Trap - GuruFocus
Going concern warning and high risk profile at Aptorum Group (NASDAQ: APM) - Stock Titan
Aptorum (NASDAQ: APM) delays DiamiR merger cutoff to June 30, 2026 - Stock Titan
If You Invested $1,000 in Aptorum Group Ltd (APM) - Stock Titan
Aptorum Group (APM) Stock Analysis Report | Financials & Insights - Benzinga Japan
[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC FilingForm 6-K - Stock Titan
Aptorum, DiamiR publish glioblastoma blood test study By Investing.com - Investing.com South Africa
Aptorum, DiamiR publish glioblastoma blood test study - Investing.com Nigeria
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - Bitget
Blood test study takes aim at glioblastoma, deadliest brain cancer - Stock Titan
User - The Chronicle-Journal
Aptorum Group Receives Nasdaq Compliance Notification - Intellectia AI
APM | Aptorum Group Limited Class FinancialsIncome Statement - Quiver Quantitative
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - The Chronicle-Journal
APM Should I Buy - Intellectia AI
Aptorum Group Limited (NASDAQ:APM) Short Interest Up 232.3% in February - Defense World
Aptorum Group Ltd (APM) Income Statement - TradingKey
APMAptorum Group Ltd Latest Stock News & Market Updates - Stock Titan
Can Aptorum Group Limited stock outperform in a bear marketTrade Risk Summary & Target Return Focused Stock Picks - mfd.ru
APM PE Ratio & Valuation, Is APM Overvalued - Intellectia AI
Exit Recap: Is Aptorum Group Limited forming a double bottom2025 Support & Resistance & Weekly Top Stock Performers List - baoquankhu1.vn
CEO Change: Will Aptorum Group Limited stock hit new highs in YEARTrade Performance Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Aptorum Group schedules 2025 annual general meeting for March in Hong Kong By Investing.com - Investing.com South Africa
Aptorum Group schedules 2025 annual general meeting for March in Hong Kong - Investing.com
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease - The Manila Times
Will Aptorum Group Limited outperform small cap indexes2025 Risk Factors & Precise Buy Zone Identification - mfd.ru
Andean Precious Metals Announces C$83.1 Million Bought Public Secondary Offering of Common Shares - markets.businessinsider.com
Trend Recap: Can Aptorum Group Limited continue delivering strong returnsJuly 2025 Intraday Action & Expert Approved Momentum Ideas - baoquankhu1.vn
Aptorum Group (NASDAQ:APM) vs. BioNxt Solutions (OTCMKTS:BNXTF) Head-To-Head Review - Defense World
Can Aptorum Group Limited stock hit analyst price targetsJuly 2025 Update & Daily Chart Pattern Signal Reports - Улправда
Sentiment Review: Will Aptorum Group Limited stock benefit from upcoming earnings reportsJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - Улправда
Aptorum Group Limited (NASDAQ:APM) Sees Significant Decline in Short Interest - Defense World
Aptorum Group (NASDAQ:APM) Stock Price Up 3.5% – Should You Buy? - Defense World
How interest rate cuts could boost Aptorum Group Limited stockQuarterly Trade Report & Community Verified Watchlist Alerts - Улправда
Can Aptorum Group Limited stock beat market expectations this quarter2025 Support & Resistance & Fast Entry High Yield Stock Tips - Улправда
DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference - Yahoo Finance
eToro adds 40 US stocks to lineup of investment instruments - FX News Group
Yam for maam: Aptorum Group to launch women’s bone health supplement made from Chinese yam - NutraIngredients.com
Up to $6M: Aptorum Group to Sell 1,000,000 Shares in Registered Direct Offering - Stock Titan
As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives - Yahoo Finance
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):